Radiolabelling and preclinical characterisation of [ < sup > 89 < /sup > Zr]Zr-Df-ATG-101 bispecific to PD-L1/4-1BB

CONCLUSION: [89Zr]Zr-Df-ATG-101 in vivo distribution is dependent on PD-L1 expression in the MDA-MB-231 xenograft model. Immuno-PET with [89Zr]Zr-Df-ATG-101 provides real-time information about ATG-101 distribution and tumour uptake in vivo. Our data support the use of [89Zr]Zr-Df-ATG-101 to assess tumour and tissue uptake of ATG-101.PMID:38730087 | DOI:10.1007/s00259-024-06742-6
Source: Molecular Medicine - Category: Molecular Biology Authors: Source Type: research